28 results
Type of content
News Remove News filter
Patient safety
Yes Remove Yes filter
-
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021 -
List item
News: PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids
PRAC, Last updated: 04/09/2020 -
List item
Press release: Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors
PRAC, Last updated: 15/05/2020 -
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
Press release: Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
PRAC, Last updated: 13/03/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
PRAC, Last updated: 14/02/2020 -
List item
Press release: EMA suspends Picato as a precaution while review of skin cancer risk continues
PRAC, Last updated: 17/01/2020 -
List item
Press release: PRAC confirms four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 17/01/2020 -
List item
Press release: Four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 04/10/2019 -
List item
Press release: PRAC recommends new measures to avoid dosing errors with methotrexate
PRAC, Last updated: 12/07/2019 -
List item
Press release: Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs
PRAC, Last updated: 17/05/2019 -
List item
Press release: Withdrawal of marketing authorisations for fenspiride medicines
PRAC, Last updated: 17/05/2019 -
List item
Press release: Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
PRAC, Last updated: 12/04/2019 -
List item
Press release: Suspension of fenspiride medicines due to potential risk of heart rhythm problems
PRAC, Last updated: 15/02/2019 -
List item
Press release: Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects
PRAC, Last updated: 05/10/2018 -
List item
Press release: EMA review of Zinbryta confirms medicine's risks outweigh its benefits
PRAC, Last updated: 18/05/2018 -
List item
Press release: New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir
PRAC, Last updated: 18/05/2018 -
List item
Press release: Eye injuries in people and dogs when using Osurnia ear gel for dogs
CVMP, Last updated: 20/04/2018 -
List item
Press release: EMA reviewing risk of dosing errors with methotrexate
PRAC, Last updated: 13/04/2018 -
List item
Press release: Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone
PRAC, Last updated: 09/03/2018 -
List item
Press release: EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
PRAC, Last updated: 02/03/2018 -
List item
Press release: PRAC recommends new measures to avoid valproate exposure in pregnancy
PRAC, Last updated: 09/02/2018 -
List item
Press release: Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
PRAC, Last updated: 09/02/2018 -
List item
Press release: EMA starts new review of hydroxyethyl-starch containing medicines
PRAC, Last updated: 27/10/2017 -
List item
Press release: Review of flupirtine-containing medicines started
PRAC, Last updated: 27/10/2017